Cancer care is not only about individual health but also financial health
A new article in JAMA Oncology is raising awareness of the disastrous consequences cancer treatment could have on the financial health of patients.
There is substantial evidence that high financial burden could lead to decreased clinical benefits due to poor treatment adherence and deteriorating quality of life. This is a challenge for oncologists as they are looking to provide the best care for each patient. But what happen if she or he cannot afford it?
The authors suggest several measures to improve patients’financial health:
– Restructure cost sharing and insurance design. Due to the current US insurance system designed with deductibles, copays and tiering, cancer patients could face extreme financial burden and, consequently poor health outcomes. Deteriorating health is tied to unaffordable treatments involving lack of adherence.
– Eliminate low-value prescribing practices. Common high-cost practices that do not improve clinical outcomes should be excluded in order to preserve patients’financial health.
– Create tools to evaluate patient risk regarding financial distress. The routine assessment of financial health should be done early and, if necessary, patient could be addressed to dedicated programs to facilitate care access like patient assistance programs offered by charities.
– Improve cost transparency. Providing this information as well as out-of-the-pocket cost information are valuable and allow patients to choose healthcare providers to minimize the impact on their personal budget.
– Provide financial counseling as part of cancer care. Patients need to understand what impact(s) their cancer diagnosis could have on their private life (employment, future income, family financial security,…). It is crucial in order to avoid financial pressure and improve planning for the patient’s family and relatives.
Express Scripts is also concerned about the price of cancer drugs as shown in a recent article. As a payer, it would like to really focus on value-based reimbursement and implement indication-based formularies. They will allow to better decide on which treatment/drug works best for which patient. Today, several tools are available to improve treatment decision like tumor testing, genetic analysis, predictive analytics,… Integrated care along with better claims management will complement the measures discussed above in order to provide real solutions and benefits for the patients.
Drug Abacus – Interactive Exploration of Drug Pricing – 2015 – Memorial Sloan Kettering
How Much Should Cancer Drugs Cost? – 2015 – WSJ
New Cancer Drugs are Expensive, but Price Controls are Misguided – 2015 – Forbes
Pricing in the Market for Anticancer Drugs – 2015 – Journal of Economic Perspectives
The High Cost of Cancer Drugs and What We Can Do About It – 2012 – Mayo Clinic Proceedings